Oxford Biodynamics (OBD) RNS Announcements

Add to Alert list
Date Time Source Announcement
09 Jul 2019 07:00 AM
RNS
Director/PDMR Shareholding
13 Jun 2019 07:00 AM
RNS
OBD appoints Dr Bartu Ahiska
12 Jun 2019 07:00 AM
RNS
PDMR Dealing / Grant of Share Options
06 Jun 2019 03:14 PM
RNS
Director/PDMR Shareholding
31 May 2019 07:00 AM
RNS
Board Transition
28 May 2019 07:00 AM
RNS
Interim Results for 6 months ended 31 March 2019
08 May 2019 07:00 AM
RNS
OBD to present at China BIO Conference
03 May 2019 02:00 PM
RNS
OBD joins ALS Biomarker study sponsored by MTPA
29 Apr 2019 07:50 AM
RNS
Notice of Interim Results
23 Apr 2019 07:00 AM
RNS
Queen's Award for Enterprise
05 Apr 2019 09:30 AM
RNS
Board Appointments
02 Apr 2019 07:00 AM
RNS
OBD US subsidiary and commercial lead
19 Mar 2019 07:00 AM
RNS
OBD joins Imperial in a prostate cancer trial
14 Mar 2019 02:13 PM
RNS
Results of Annual General Meeting
15 Feb 2019 10:01 AM
RNS
Director/PDMR Shareholding
25 Jan 2019 07:00 AM
RNS
Publication of Annual Report and Notice of AGM
11 Jan 2019 07:00 AM
RNS
Board Transition
11 Dec 2018 07:00 AM
RNS
Final Results
03 Dec 2018 10:10 AM
RNS
Total Voting Rights
23 Nov 2018 07:00 AM
RNS
Notice of results for year ended 30 Sept 2018
12 Nov 2018 07:00 AM
RNS
Collaboration into identifying diagnosis of Autism
08 Nov 2018 07:00 AM
RNS
OBD signs fifth collaboration agreement
07 Nov 2018 07:00 AM
RNS
Study published in Faculty of 1000 Research
06 Nov 2018 07:00 AM
RNS
Issue of Equity
01 Nov 2018 05:17 PM
RNS
Total Voting Rights
02 Oct 2018 07:00 AM
RNS
Issue of Equity
26 Sep 2018 07:00 AM
RNS
Issue of Equity
18 Sep 2018 07:00 AM
RNS
Consortium with OBD receives ?4m Horizon 2020 fund
04 Sep 2018 10:03 AM
RNS
Total Voting Rights
30 Aug 2018 02:57 PM
RNS
Holding(s) in Company
29 Aug 2018 04:52 PM
RNS
Holding(s) in Company
29 Aug 2018 04:48 PM
RNS
Holding(s) in Company
29 Aug 2018 04:47 PM
RNS
Holding(s) in Company
29 Aug 2018 04:46 PM
RNS
Holding(s) in Company
29 Aug 2018 04:43 PM
RNS
Holding(s) in Company
22 Aug 2018 07:00 AM
RNS
Chinese Investment Group Takes Stake in OBD
19 Jul 2018 07:00 AM
RNS
Grant of Canadian patent for EpiSwitch platform
17 Jul 2018 07:00 AM
RNS
OBD presents latest EpiSwitch data at ASH Summit
02 Jul 2018 05:50 PM
RNS
Total Voting Rights
26 Jun 2018 07:00 AM
RNS
ALS study published in peer reviewed journal
19 Jun 2018 07:00 AM
RNS
Issue of Equity
22 May 2018 07:00 AM
RNS
Interim Results for the Period Ended 31 March 2018
01 May 2018 07:00 AM
RNS
Total Voting Rights
17 Apr 2018 07:00 AM
RNS
Notice of Interim Results
05 Apr 2018 11:41 AM
RNS
Issue of Equity
28 Mar 2018 07:00 AM
RNS
Publication in Journal of Translational Medicine
19 Mar 2018 07:00 AM
RNS
PDMR Dealing/Grant of Share Options
16 Mar 2018 07:00 AM
RNS
ALS biomarker data presented at World CNS Summit
15 Mar 2018 02:10 PM
RNS
Results of Annual General Meeting
15 Feb 2018 07:00 AM
RNS
Publication of Annual Report and Notice of AGM

Oxford Biodynamics' international store for clinical smart tests and research kits based on pioneering EpiSwitch® 3D genomic technology.

OBD was spun out of Oxford University in 2007 to commercialize blood tests based on 3D Genomics research. OBD's tests are designed to help people make informed health decisions and reduce healthcare costs.

OBD share price launched at 162p in 2016.

UK 100

Latest directors dealings